Yahoo Finance

Morphogenesis, Inc to Present at the Virtual Investor Summer Spotlight Series

TAMPA, FL / ACCESSWIRE / July 6, 2023 / Morphogenesis, Inc. ("Morphogenesis"), a privately-held Phase 2/3 clinical-stage biotechnology company developing novel personalized cancer vaccines and tumor ...
Yahoo Finance

Morphogenesis, Inc. and CohBar, Inc. Announce Acceptance of Abstract for Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Morphogenesis and CohBar recently announced that they have entered into a definitive merger agreement for an all-stock transaction to form a company combining expertise and resources to advance a late ...
WFLA

Tampa’s ‘Morphogenesis’ continues skin cancer vaccine efforts with new CEO

TAMPA, Fla. (WFLA) – A Tampa company developing a skin cancer vaccine has recently appointed a new CEO who plans to take the company public within the next few months. Dr. James Bianco, an oncologist ...
Miami Herald

Morphogenesis, Inc. Announces Corporate Rebranding to TuHURA Biosciences, Inc. and Provides a Business Overview

TAMPA, FL / ACCESSWIRE / December 14, 2023 / Morphogenesis, Inc. ("Morphogenesis"), a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer ...